Kangstem Biotech Co. Ltd (217730) — Working Capital to Net Assets Ratio
Kangstem Biotech Co. Ltd (217730) has a Working Capital to Net Assets ratio of 41.5% as of June 2026. Working capital of ₩23.46 Billion (current assets of ₩31.38 Billion minus current liabilities of ₩7.93 Billion) is measured against net assets of ₩56.56 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of Kangstem Biotech Co. Ltd to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Kangstem Biotech Co. Ltd Working Capital to Net Assets (2015–2025)
This chart shows how Kangstem Biotech Co. Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 41.5%, reflecting working capital of ₩23.46 Billion against net assets of ₩56.56 Billion KRW. For the complete balance sheet picture, see 217730 total assets.
Annual Working Capital to Net Assets for Kangstem Biotech Co. Ltd (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Kangstem Biotech Co. Ltd from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 217730 financial resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 51.2% | ₩35.33 Billion | ₩69.06 Billion | ₩43.63 Billion | ₩8.30 Billion | ▲ +3.0 pp |
| 2024 | 48.2% | ₩20.80 Billion | ₩43.18 Billion | ₩28.53 Billion | ₩7.73 Billion | ▼ -3.9 pp |
| 2023 | 52.0% | ₩23.17 Billion | ₩44.52 Billion | ₩47.37 Billion | ₩24.20 Billion | ▼ -14.9 pp |
| 2022 | 66.9% | ₩31.64 Billion | ₩47.26 Billion | ₩45.91 Billion | ₩14.27 Billion | ▼ -3.8 pp |
| 2021 | 70.8% | ₩48.16 Billion | ₩68.07 Billion | ₩65.36 Billion | ₩17.19 Billion | ▲ +7.7 pp |
| 2020 | 63.0% | ₩32.54 Billion | ₩51.62 Billion | ₩44.75 Billion | ₩12.21 Billion | ▲ +13.8 pp |
| 2019 | 49.2% | ₩34.81 Billion | ₩70.72 Billion | ₩55.41 Billion | ₩20.60 Billion | ▼ -11.5 pp |
| 2018 | 60.7% | ₩28.94 Billion | ₩47.69 Billion | ₩48.99 Billion | ₩20.06 Billion | ▼ -19.7 pp |
| 2017 | 80.4% | ₩18.88 Billion | ₩23.47 Billion | ₩25.25 Billion | ₩6.37 Billion | ▼ -70.8 pp |
| 2016 | 151.2% | ₩34.74 Billion | ₩22.98 Billion | ₩37.97 Billion | ₩3.23 Billion | ▲ +76.2 pp |
| 2015 | 75.0% | ₩15.93 Billion | ₩21.24 Billion | ₩18.90 Billion | ₩2.97 Billion | — |